Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
DNA Repair (Amst) ; 94: 102937, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32693352

RESUMO

Xeroderma pigmentosum complementation group A (XPA), is defective in xeroderma pigmentosum patients, causing pre-disposition to skin cancer and neurological abnormalities, which is not well understood. Here, we analyzed the XPA-deficient cells transcriptional profile under oxidative stress. The imbalance in of ubiquitin-proteasome system (UPS) gene expression was observed in XPA-deficient cells and the involvement of nuclear factor erythroid 2-related factor-2 (NFE2L2) was indicated. Co-immunoprecipitation assays showed the interaction between XPA, apurinic-apyrimidinic endonuclease 1 (APE1) and NFE2L2 proteins. Decreased NFE2L2 protein expression and proteasome activity was also observed in XPA-deficient cells. The data suggest the involvement of the growth arrest and DNA-damage-inducible beta (GADD45ß) in NFE2L2 functions. Similar results were obtained in xpa-1 (RNAi) Caenorhabditis elegans suggesting the conservation of XPA and NFE2L2 interactions. In conclusion, stress response activation occurs in XPA-deficient cells under oxidative stress; however, these cells fail to activate the UPS cytoprotective response, which may contribute to XPA patient's phenotypes.


Assuntos
Fator 2 Relacionado a NF-E2/metabolismo , Estresse Oxidativo , Complexo de Endopeptidases do Proteassoma/metabolismo , Proteostase , Ubiquitina/metabolismo , Proteína de Xeroderma Pigmentoso Grupo A/metabolismo , Células Cultivadas , Reparo do DNA , DNA Liase (Sítios Apurínicos ou Apirimidínicos)/metabolismo , Regulação para Baixo , Perfilação da Expressão Gênica , Regulação da Expressão Gênica , Humanos , Proteína de Xeroderma Pigmentoso Grupo A/genética
4.
Hum Mol Genet ; 25(7): 1271-80, 2016 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-26755826

RESUMO

Cockayne syndrome (CS) is a rare genetic disorder in which 80% of cases are caused by mutations in the Excision Repair Cross-Complementation group 6 gene (ERCC6). The encoded ERCC6 protein is more commonly referred to as Cockayne Syndrome B protein (CSB). Classical symptoms of CS patients include failure to thrive and a severe neuropathology characterized by microcephaly, hypomyelination, calcification and neuronal loss. Modeling the neurological aspect of this disease has proven difficult since murine models fail to mirror classical neurological symptoms. Therefore, a robust human in vitro cellular model would advance our fundamental understanding of the disease and reveal potential therapeutic targets. Herein, we successfully derived functional CS neural networks from human CS induced pluripotent stem cells (iPSCs) providing a new tool to facilitate studying this devastating disease. We identified dysregulation of the Growth Hormone/Insulin-like Growth Factor-1 (GH/IGF-1) pathway as well as pathways related to synapse formation, maintenance and neuronal differentiation in CSB neurons using unbiased RNA-seq gene expression analyses. Moreover, when compared to unaffected controls, CSB-deficient neural networks displayed altered electrophysiological activity, including decreased synchrony, and reduced synapse density. Collectively, our work reveals that CSB is required for normal neuronal function and we have established an alternative to previously available models to further study neural-specific aspects of CS.


Assuntos
Síndrome de Cockayne/fisiopatologia , DNA Helicases/metabolismo , Enzimas Reparadoras do DNA/metabolismo , Fenômenos Eletrofisiológicos , Mutação , Rede Nervosa/fisiopatologia , Neurônios/fisiologia , Adolescente , Adulto , Diferenciação Celular , Linhagem Celular , Criança , Pré-Escolar , Síndrome de Cockayne/genética , Síndrome de Cockayne/metabolismo , DNA Helicases/genética , Reparo do DNA , Enzimas Reparadoras do DNA/genética , Feminino , Hormônio do Crescimento , Humanos , Células-Tronco Pluripotentes Induzidas/fisiologia , Fator de Crescimento Insulin-Like I , Masculino , Rede Nervosa/metabolismo , Neurônios/metabolismo , Proteínas de Ligação a Poli-ADP-Ribose , Transdução de Sinais , Sinapses/metabolismo , Sinapses/fisiologia
5.
BMC Microbiol ; 15: 115, 2015 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-26048053

RESUMO

BACKGROUND: Violacein is a purple pigment from Chromobacterium violaceum that possesses diverse biological and pharmacological properties. Among these, pro-oxidant and antioxidant activities have been suggested. However, the cytotoxic mechanisms induced by violacein are poorly understood and the improvement in knowledge regarding these cell death mechanisms will be useful to develop new therapeutic approaches. Considering this, in our work, we investigated the pro-oxidant effects of violacein in non-tumor (CHO-K1 and MRC-5) and tumor (HeLa) cell lines, searching for a better understanding of reactive oxygen species (ROS) production and cell death induction. RESULTS: Cytotoxicity induced by violacein was observed in the three cell lines; however, MRC-5 and HeLa cells were shown to be more sensitive to violacein treatment. Although punctual alterations in the antioxidant apparatus and increase in oxidative stress biomarkers was observed in some violacein concentrations, no association was found between increased oxidative stress and induction of cell death. However, the increase of mitochondrial membrane potential was observed. CONCLUSIONS: In fact, the increase of mitochondrial membrane potential in MRC-5 and HeLa cells suggests that mitochondrial membrane hyperpolarization might be the main cause of cell death triggered by violacein.


Assuntos
Indóis/toxicidade , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo , Animais , Células CHO , Morte Celular , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Cricetulus , Células HeLa , Humanos , Indóis/farmacologia
6.
Toxicol In Vitro ; 28(3): 381-7, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24296152

RESUMO

Titanium is one of the most used materials in implants and changes in its surface can modify the cellular functional response to better implant fixation. An argon plasma treatment generates a surface with improved mechanical proprieties without modifying its chemical composition. Oxidative stress induced by biomaterials is considered one of the major causes of implant failure and studies in this field are fundamental to evaluate the biocompatibility of a new material. Therefore, in this work, induction of oxidative stress by titanium surfaces subjected to plasma treatment (PTTS) was evaluated. The viability of CHO-k1 cells was higher on PTTS discs. Cells grown on titanium surfaces are subjected to intracellular oxidative stress. Titanium discs subjected to the plasma treatment induced less oxidative stress than the untreated ones, which resulted in improved cellular survival. These were associated with improved cellular antioxidant response in Plasma Treated Titanium Surface (PTTS). Furthermore, a decrease in protein and DNA oxidative damage was observed on cells grown on the roughed surface when compared to the smooth one. In conclusion, our data suggest that the treatment of titanium with argon plasma may improve its biocompatible, thus improving its performance as implants or as a scaffold in tissue engineering.


Assuntos
Antioxidantes/metabolismo , Argônio/química , Materiais Biocompatíveis/química , Titânio/química , Animais , Células CHO , Sobrevivência Celular , Cricetinae , Cricetulus , Dano ao DNA , Estresse Oxidativo , Próteses e Implantes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...